US telemedicine company owner charged with $784m fraud

A jury in the US has charged a Florida man who owns multiple telemedicine companies in connection with a massive healthcare scam that involved a massive $784 million in fraudulent claims be

US starts review of Aduhelm coverage amid fears of Medicare ...

The US government has started a review of how Biogen and Eisai's pricey new Alzheimer's disease therapy Aduhelm will be covered by Medicare, to see if a national strategy needs to be adopte

Biden administration – What can the healthcare industry expe...

As Joe Biden takes the reins at the White House, pharmaphorum asks experts how his presidential tenure may influence the global healthcare industry.

As COVID-19 cases swell, US extends telehealth to acute care

The US government has introduced a scheme to allow hospitals to reduce the number of inpatients they see through a telehealth platform that would helps deliver acute care at home.<

US relaxes telemedicine rules as COVID-19 outbreak gathers p...

Republican revolt threatens Senate drug pricing bill